6.
Santic Z, Pravdic N, Bevanda M, Galic K
. The historical use of medicinal plants in traditional and scientific medicine. Psychiatr Danub. 2017; 29 Suppl 4(Suppl 4):787-792.
View
7.
Tseng J, Chen C, Chen P, Hsiao S, Fan C, Liang Y
. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression. Oncotarget. 2017; 8(9):14666-14679.
PMC: 5362434.
DOI: 10.18632/oncotarget.14716.
View
8.
Medina-Diaz I, Ponce-Ruiz N, Rojas-Garcia A, Zambrano-Zargoza J, Bernal-Hernandez Y, Gonzalez-Arias C
. The Relationship between Cancer and Paraoxonase 1. Antioxidants (Basel). 2022; 11(4).
PMC: 9028432.
DOI: 10.3390/antiox11040697.
View
9.
Pflaum J, Schlosser S, Muller M
. p53 Family and Cellular Stress Responses in Cancer. Front Oncol. 2014; 4:285.
PMC: 4204435.
DOI: 10.3389/fonc.2014.00285.
View
10.
Tapsell L, Hemphill I, Cobiac L, Patch C, Sullivan D, Fenech M
. Health benefits of herbs and spices: the past, the present, the future. Med J Aust. 2006; 185(S4):S1-S24.
DOI: 10.5694/j.1326-5377.2006.tb00548.x.
View
11.
Mena S, Ortega A, Estrela J
. Oxidative stress in environmental-induced carcinogenesis. Mutat Res. 2008; 674(1-2):36-44.
DOI: 10.1016/j.mrgentox.2008.09.017.
View
12.
Litvinov D, Mahini H, Garelnabi M
. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci. 2012; 4(11):523-32.
PMC: 3503369.
DOI: 10.4103/1947-2714.103310.
View
13.
Mutlu M, Korkmaz M, Simsek E, Terzi E, Oz Bedir B, Uysal T
. Do CO and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients. J Enzyme Inhib Med Chem. 2019; 34(1):459-464.
PMC: 6327982.
DOI: 10.1080/14756366.2018.1555157.
View
14.
Kaya M, Sinan S, Ozensoy Guler O, Arslan O
. Is there a relation between genetic susceptibility with cancer? A study about paraoxanase (PON1) enzyme activity in breast cancer cases. J Enzyme Inhib Med Chem. 2016; 31(6):1349-55.
DOI: 10.3109/14756366.2015.1134523.
View
15.
Mackness M, Mackness B
. Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles. Gene. 2015; 567(1):12-21.
PMC: 4458450.
DOI: 10.1016/j.gene.2015.04.088.
View
16.
Das A, Banik N, Ray S
. Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells. Cancer Invest. 2008; 26(4):352-8.
DOI: 10.1080/07357900701788080.
View
17.
Valko M, Rhodes C, Moncol J, Izakovic M, Mazur M
. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006; 160(1):1-40.
DOI: 10.1016/j.cbi.2005.12.009.
View
18.
Martinez C, Molina J, Alonso-Navarro H, Jimenez-Jimenez F, Agundez J, Garcia-Martin E
. Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol. 2010; 10:71.
PMC: 2936881.
DOI: 10.1186/1471-2377-10-71.
View
19.
Greene C, Campbell M
. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016; 4(1):e1138017.
PMC: 4836485.
DOI: 10.1080/21688370.2015.1138017.
View
20.
Taghizadehghalehjoughi A, Hacimuftuoglu A, Cetin M, Ugur A, Galateanu B, Mezhuev Y
. Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies. Nanomedicine (Lond). 2018; 13(13):1595-1606.
DOI: 10.2217/nnm-2017-0386.
View